Cargando…
New Perspectives to Improve Mesenchymal Stem Cell Therapies for Drug-Induced Liver Injury
Drug-induced liver injury (DILI) is one of the leading causes of acute liver injury. Many factors may contribute to the susceptibility of patients to this condition, making DILI a global medical problem that has an impact on public health and the pharmaceutical industry. The use of mesenchymal stem...
Autores principales: | Ezquer, Fernando, Huang, Ya-Lin, Ezquer, Marcelo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8910533/ https://www.ncbi.nlm.nih.gov/pubmed/35269830 http://dx.doi.org/10.3390/ijms23052669 |
Ejemplares similares
-
Administration of multipotent mesenchymal stromal cells restores liver regeneration and improves liver function in obese mice with hepatic steatosis after partial hepatectomy
por: Ezquer, Fernando, et al.
Publicado: (2017) -
Administration of Secretome Derived from Human Mesenchymal Stem Cells Induces Hepatoprotective Effects in Models of Idiosyncratic Drug-Induced Liver Injury Caused by Amiodarone or Tamoxifen
por: Huang, Ya-Lin, et al.
Publicado: (2023) -
Improving Cell Recovery: Freezing and Thawing Optimization of Induced Pluripotent Stem Cells
por: Uhrig, Markus, et al.
Publicado: (2022) -
Mesenchymal stem cell therapy for doxorubicin cardiomyopathy: hopes and fears
por: Ezquer, Fernando, et al.
Publicado: (2015) -
Two complementary strategies to improve cell engraftment in mesenchymal stem cell-based therapy: Increasing transplanted cell resistance and increasing tissue receptivity
por: Ezquer, Fernando E., et al.
Publicado: (2016)